Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Journal of Biopharmaceutical Statistics
|
September 25, 2015
Trends and innovations in clinical trial statistics
Olga Marchenko, Alex Dmitrienko
Journal of Biopharmaceutical Statistics
|
December 16, 2016
Special Issue of Journal of Biopharmaceutical Statistics dedicated to 2016 Trends and Innovations in Clinical Trial Statistics (TICTS) Conference
Marie Davidian, Anastasia Ivanova, Olga Marchenko
Journal of Biopharmaceutical Statistics
|
March 14, 2017
Bridging data across studies using frequentist and Bayesian estimation
Teng Zhang, Ilya Lipkovich, Olga Marchenko
Journal of Biopharmaceutical Statistics
|
October 22, 2013
Selection of hypothesis weights and ordering when testing multiple hypotheses in clinical trials
Brian L Wiens, Alex Dmitrienko, Olga Marchenko
Clinical Trials (London, England)
|
December 7, 2014
Commentary: preserving confidentiality of interim data
Christy Chuang-Stein, Qi Jiang, Olga Marchenko
Journal of Biopharmaceutical Statistics
|
September 18, 2015
Practical designs for Phase I combination studies in oncology
Nolan A Wages, Anastasia Ivanova, Olga Marchenko
Therapeutic Innovation & Regulatory Science
|
September 21, 2018
Adaptive Design Applied to Identification of the Minimum Effective Dose in Schizophrenia: Simulations of Scientific and Commercial Value
Tom Parke, Vladimir Dragalin, Ibrahim Turkoz, et al.
Journal of Biopharmaceutical Statistics
|
March 11, 2017
Joint modeling of time to recurrence and cancer stage at recurrence in oncology trials
Olga Marchenko, Alex Tsodikov, Robert Keener, et al.
Therapeutic Innovation & Regulatory Science
|
July 4, 2017
Adaptive Clinical Trials: Overview of Early-Phase Designs and Challenges
Olga Marchenko, Valerii Fedorov, J Jack Lee, et al.
Therapeutic Innovation & Regulatory Science
|
September 22, 2018
Improving Oncology Clinical Programs by Use of Innovative Designs and Comparing Them via Simulations
Olga Marchenko, Joel Miller, Tom Parke, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Journal of Biopharmaceutical Statistics
|
September 25, 2015
Trends and innovations in clinical trial statistics
Olga Marchenko, Alex Dmitrienko
Journal of Biopharmaceutical Statistics
|
December 16, 2016
Special Issue of Journal of Biopharmaceutical Statistics dedicated to 2016 Trends and Innovations in Clinical Trial Statistics (TICTS) Conference
Marie Davidian, Anastasia Ivanova, Olga Marchenko
Journal of Biopharmaceutical Statistics
|
March 14, 2017
Bridging data across studies using frequentist and Bayesian estimation
Teng Zhang, Ilya Lipkovich, Olga Marchenko
Journal of Biopharmaceutical Statistics
|
October 22, 2013
Selection of hypothesis weights and ordering when testing multiple hypotheses in clinical trials
Brian L Wiens, Alex Dmitrienko, Olga Marchenko
Clinical Trials (London, England)
|
December 7, 2014
Commentary: preserving confidentiality of interim data
Christy Chuang-Stein, Qi Jiang, Olga Marchenko
Journal of Biopharmaceutical Statistics
|
September 18, 2015
Practical designs for Phase I combination studies in oncology
Nolan A Wages, Anastasia Ivanova, Olga Marchenko
Therapeutic Innovation & Regulatory Science
|
September 21, 2018
Adaptive Design Applied to Identification of the Minimum Effective Dose in Schizophrenia: Simulations of Scientific and Commercial Value
Tom Parke, Vladimir Dragalin, Ibrahim Turkoz, et al.
Journal of Biopharmaceutical Statistics
|
March 11, 2017
Joint modeling of time to recurrence and cancer stage at recurrence in oncology trials
Olga Marchenko, Alex Tsodikov, Robert Keener, et al.
Therapeutic Innovation & Regulatory Science
|
July 4, 2017
Adaptive Clinical Trials: Overview of Early-Phase Designs and Challenges
Olga Marchenko, Valerii Fedorov, J Jack Lee, et al.
Therapeutic Innovation & Regulatory Science
|
September 22, 2018
Improving Oncology Clinical Programs by Use of Innovative Designs and Comparing Them via Simulations
Olga Marchenko, Joel Miller, Tom Parke, et al.
Page
of 3